Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 2,537 $ 434
Marketable debt securities, available for sale 3,339 926
Escrow receivable 4,812
Accounts receivable, net 1,930 2,010
Inventory 2,047 1,459
Prepaid expenses and other current assets 213 304
Assets held for sale 176
Total current assets 10,242 9,945
Property, plant and equipment, net of accumulated depreciation of $6,379 and $6,252, respectively 2,133 2,329
TOTAL ASSETS 12,375 12,274
Current liabilities    
Accounts payable 844 432
Accrued advertising and other allowances 112 92
Other current liabilities 439 409
Total current liabilities 1,395 933
Non-current liabilities:    
Deferred revenue, net of current portion 86 110
Total non-current liabilities 86 110
Total liabilities 1,481 1,043
COMMITMENTS AND CONTINGENCIES
Stockholders' equity    
Preferred stock authorized 1,000,000, $.0005 par value, no shares issued
Common stock authorized 50,000,000, $.0005 par value, issued 28,243,670 and 28,225,615 shares, respectively 14 14
Additional paid-in capital 60,611 60,215
Accumulated deficit (2,245) (1,506)
Treasury stock, at cost, 16,652,022 and 16,652,022 shares (47,490) (47,490)
Accumulated comprehensive income (loss) 4 (2)
Total stockholders' equity 10,894 11,231
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 12,375 $ 12,274